{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:14:41Z","timestamp":1792682081275,"version":"4.5.0"},"reference-count":198,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute myeloid leukemia (AML) is caused by altered maturation and differentiation of myeloid blasts, as well as transcriptional\/epigenetic alterations, all leading to excessive proliferation of malignant blood cells in the bone marrow. Tumor heterogeneity due to the acquisition of new somatic alterations leads to a high rate of resistance to current therapies or reduces the efficacy of hematopoietic stem cell transplantation (HSCT), thus increasing the risk of relapse and mortality. Single-cell RNA sequencing (scRNA-seq) will enable the classification of AML and guide treatment approaches by profiling patients with different facets of the same disease, stratifying risk, and identifying new potential therapeutic targets at the time of diagnosis or after treatment. ScRNA-seq allows the identification of quiescent stem-like cells, and leukemia stem cells responsible for resistance to therapeutic approaches and relapse after treatment. This method also introduces the factors and mechanisms that enhance the efficacy of the HSCT process. Generated data of the transcriptional profile of the AML could even allow the development of cancer vaccines and CAR T-cell therapies while saving valuable time and alleviating dangerous side effects of chemotherapy and HSCT in vivo. However, scRNA-seq applications face various challenges such as a large amount of data for high-dimensional analysis, technical noise, batch effects, and finding small biological patterns, which could be improved in combination with artificial intelligence models.<\/jats:p>","DOI":"10.1186\/s10020-025-01085-w","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T13:39:29Z","timestamp":1738244369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Single cell RNA sequencing improves the next generation of approaches to AML treatment: challenges and perspectives"],"prefix":"10.1186","volume":"31","author":[{"given":"Zahra","family":"Khosroabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Azaryar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Dianat-Moghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Amoozgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"issue":"1","key":"1085_CR1","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.1038\/s41467-021-26282-z","volume":"12","author":"HA Abbas","year":"2021","unstructured":"Abbas HA, Hao D, Tomczak K, Barrodia P, Im JS, Reville PK, et al. Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy. Nat Commun. 2021;12(1):6071.","journal-title":"Nat Commun"},{"issue":"5","key":"1085_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nbt.3209","volume":"33","author":"K Achim","year":"2015","unstructured":"Achim K, Pettit J-B, Saraiva LR, Gavriouchkina D, Larsson T, Arendt D, et al. High-throughput spatial mapping of single-cell RNA-seq data to tissue of origin. Nat Biotechnol. 2015;33(5):503\u20139.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"1085_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41592-018-0019-x","volume":"15","author":"N Altman","year":"2018","unstructured":"Altman N, Krzywinski M. The curse (s) of dimensionality. Nat Methods. 2018;15(6):399\u2013400.","journal-title":"Nat Methods"},{"key":"1085_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2020-141622","volume":"136","author":"C Andreadis","year":"2020","unstructured":"Andreadis C, Jiang T, Wang V, Patel R, Rao A, Ye CJ, et al. Analysis of multiplexed single cell RNA sequencing clinical correlative data in AML reveals biomarkers of resistance. Blood. 2020;136:40.","journal-title":"Blood"},{"key":"1085_CR5","doi-asserted-by":"crossref","unstructured":"Asimomitis G, Sirenko M, Fotis C, Landau DA, Alexopoulos LG, Papaemmanuil E. Predicting single cell genotypes from single cell expression profiles in AML using deep learning. Proceedings of the 2023 13th International Conference on Bioscience, Biochemistry and Bioinformatics; Tokyo, Japan: Association for Computing Machinery; 2023. p. 1\u20139.","DOI":"10.1145\/3586139.3586140"},{"issue":"4","key":"1085_CR6","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/annonc\/mdy050","volume":"29","author":"S Aspeslagh","year":"2018","unstructured":"Aspeslagh S, Morel D, Soria J-C, Postel-Vinay S. Epigenetic modifiers as new immunomodulatory therapies in solid tumours. Ann Oncol. 2018;29(4):812\u201324.","journal-title":"Ann Oncol"},{"issue":"10","key":"1085_CR7","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.3390\/cancers15102713","volume":"15","author":"E Atilla","year":"2023","unstructured":"Atilla E, Benabdellah K. The Black Hole: CAR T Cell Therapy in AML. Cancers (Basel). 2023;15(10):2713.","journal-title":"Cancers (Basel)."},{"issue":"5","key":"1085_CR8","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.3390\/ijms23052802","volume":"23","author":"H Awada","year":"2022","unstructured":"Awada H, Gurnari C, Durmaz A, Awada H, Pagliuca S, Visconte V. Personalized risk schemes and machine learning to empower genomic prognostication models in myelodysplastic syndromes. Int J Mol Sci. 2022;23(5):2802.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1085_CR9","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1182\/bloodadvances.2022008981","volume":"7","author":"P Bader","year":"2023","unstructured":"Bader P, Rossig C, Hutter M, Ayuk FA, Baldus CD, Bucklein VL, et al. CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany. Blood Adv. 2023;7(11):2436\u201348.","journal-title":"Blood Adv"},{"key":"1085_CR10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/bmj.2.4993.626","volume":"2","author":"DW Barnes","year":"1956","unstructured":"Barnes DW, Corp MJ, Loutit JF, Neal FE. Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication. Br Med J. 1956;2:626.","journal-title":"Br Med J"},{"issue":"7","key":"1085_CR11","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1182\/bloodadvances.2018026625","volume":"3","author":"R Bassan","year":"2019","unstructured":"Bassan R, Intermesoli T, Masciulli A, Pavoni C, Boschini C, Gianfaldoni G, et al. Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML. Blood Adv. 2019;3(7):1103\u201317.","journal-title":"Blood Adv"},{"key":"1085_CR12","first-page":"1","volume":"2024","author":"AS Bhagwat","year":"2024","unstructured":"Bhagwat AS, Torres L, Shestova O, Shestov M, Mellors PW, Fisher HR, et al. Cytokine-mediated CAR T therapy resistance in AML. Nature Med. 2024;2024:1\u201312.","journal-title":"Nature Med"},{"issue":"1","key":"1085_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","volume":"16","author":"RS Bhansali","year":"2023","unstructured":"Bhansali RS, Pratz KW, Lai C. Recent advances in targeted therapies in acute myeloid leukemia. J Hematol Oncol. 2023;16(1):29.","journal-title":"J Hematol Oncol"},{"key":"1085_CR14","unstructured":"Biosciences C. Caribou Biosciences Announces FDA Clearance of IND Application for CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia. 2023."},{"issue":"11","key":"1085_CR15","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/nmeth.2645","volume":"10","author":"P Brennecke","year":"2013","unstructured":"Brennecke P, Anders S, Kim JK, Ko\u0142odziejczyk AA, Zhang X, Proserpio V, et al. Accounting for technical noise in single-cell RNA-seq experiments. Nat Methods. 2013;10(11):1093\u20135.","journal-title":"Nat Methods"},{"key":"1085_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fmed.2020.00027","volume":"7","author":"G Briganti","year":"2020","unstructured":"Briganti G, Le Moine O. Artificial intelligence in medicine: today and tomorrow. Front Med (Lausanne). 2020;7:27.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"1085_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/19420862.2016.1268307","volume":"9","author":"U Brinkmann","year":"2017","unstructured":"Brinkmann U, Kontermann RE. The making of bispecific antibodies. Mabs. 2017;9(2):182\u2013212.","journal-title":"Mabs"},{"issue":"4","key":"1085_CR18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3390\/vaccines8040615","volume":"8","author":"L Buonaguro","year":"2020","unstructured":"Buonaguro L, Tagliamonte M. Selecting target antigens for cancer vaccine development. Vaccines (Basel). 2020;8(4):615.","journal-title":"Vaccines (Basel)."},{"key":"1085_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.796477","volume":"11","author":"C Caprioli","year":"2022","unstructured":"Caprioli C, Nazari I, Milovanovic S, Pelicci PG. Single-cell technologies to decipher the immune microenvironment in myeloid neoplasms: perspectives and opportunities. Front Oncol. 2022;11: 796477.","journal-title":"Front Oncol"},{"issue":"3","key":"1085_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41423-019-0214-4","volume":"16","author":"H Chen","year":"2019","unstructured":"Chen H, Ye F, Guo G. Revolutionizing immunology with single-cell RNA sequencing. Cell Mol Immunol. 2019a;16(3):242\u20139.","journal-title":"Cell Mol Immunol"},{"key":"1085_CR21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fgene.2019.00317","volume":"10","author":"G Chen","year":"2019","unstructured":"Chen G, Ning B, Shi T. Single-cell RNA-seq technologies and related computational data analysis. Front Genet. 2019b;10:317.","journal-title":"Front Genet"},{"key":"1085_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00317","volume":"10","author":"G Chen","year":"2019","unstructured":"Chen G, Ning B, Shi T. Single-cell RNA-seq technologies and related computational data analysis. Front Genet. 2019c;10: 441123.","journal-title":"Front Genet"},{"issue":"2","key":"1085_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.12998\/wjcc.v11.i2.268","volume":"11","author":"Y-F Chen","year":"2023","unstructured":"Chen Y-F, Li J, Xu L-L, G\u0103man M-A, Zou Z-Y. Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: an overview of obstacles and opportunities. World J Clin Cases. 2023;11(2):268\u201391.","journal-title":"World J Clin Cases"},{"key":"1085_CR24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/hon.3129","volume":"41","author":"PL Cheng","year":"2023","unstructured":"Cheng PL, Hsiao TH, Chen CH, Hung MN, Jhan PP, Lee LW, et al. Chemoresistance in acute myeloid leukemia: an alternative single-cell RNA sequencing approach. Hematol Oncol. 2023;41:499\u2013509.","journal-title":"Hematol Oncol"},{"issue":"1","key":"1085_CR25","doi-asserted-by":"publisher","first-page":"8350","DOI":"10.1038\/s41598-024-58580-z","volume":"14","author":"FM Cheng","year":"2024","unstructured":"Cheng FM, Lo SC, Lin CC, Lo WJ, Chien SY, Sun TH, et al. Deep learning assists in acute leukemia detection and cell classification via flow cytometry using the acute leukemia orientation tube. Sci Rep. 2024;14(1):8350.","journal-title":"Sci Rep"},{"issue":"1","key":"1085_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/biom13010156","volume":"13","author":"K Choe","year":"2023","unstructured":"Choe K, Pak U, Pang Y, Hao W, Yang X. Advances and challenges in spatial transcriptomics for developmental biology. Biomolecules. 2023;13(1):156.","journal-title":"Biomolecules"},{"issue":"1","key":"1085_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.iac.2009.10.001","volume":"30","author":"SW Choi","year":"2010","unstructured":"Choi SW, Levine JE, Ferrara JL. Pathogenesis and management of graft-versus-host disease. Immunol Allergy Clin North Am. 2010;30(1):75\u2013101.","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"1085_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bbmt.2016.09.023","volume":"23","author":"KR Cooke","year":"2017","unstructured":"Cooke KR, Luznik L, Sarantopoulos S, Hakim FT, Jagasia M, Fowler DH, et al. The biology of chronic graft-versus-host disease: a task force report from the national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2017;23(2):211\u201334.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"1085_CR29","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1158\/1055-9965.EPI-11-1087","volume":"21","author":"BM Craig","year":"2012","unstructured":"Craig BM, Rollison DE, List AF, Cogle CR. Underreporting of myeloid malignancies by United States cancer registries. Cancer Epidemiol Biomark Prev. 2012;21(3):474\u201381.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"1085_CR30","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1093\/bib\/bby007","volume":"20","author":"A Dal Molin","year":"2019","unstructured":"Dal Molin A, Di Camillo B. How to design a single-cell RNA-sequencing experiment: pitfalls, challenges and perspectives. Brief Bioinform. 2019;20(4):1384\u201394.","journal-title":"Brief Bioinform"},{"key":"1085_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-genom-083117-021602","volume":"19","author":"S Das","year":"2018","unstructured":"Das S, Abecasis GR, Browning BL. Genotype imputation from large reference panels. Annu Rev Genomics Hum Genet. 2018;19:73\u201396.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"3","key":"1085_CR32","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1158\/2159-8290.CD-18-0774","volume":"9","author":"N Daver","year":"2019","unstructured":"Daver N, Garcia-Manero G, Basu S, Boddu PC, Alfayez M, Cortes JE, et al. Efficacy, safety, and biomarkers of response to azacitidine and nivolumab in relapsed\/refractory acute myeloid leukemia: a nonrandomized, open-label, phase II study. Cancer Discov. 2019;9(3):370\u201383.","journal-title":"Cancer Discov"},{"issue":"7","key":"1085_CR33","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1038\/s41375-021-01253-x","volume":"35","author":"N Daver","year":"2021","unstructured":"Daver N, Alotaibi AS, B\u00fccklein V, Subklewe M. T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments. Leukemia. 2021;35(7):1843\u201363.","journal-title":"Leukemia"},{"key":"1085_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-020-02048-6","volume":"21","author":"E Denisenko","year":"2020","unstructured":"Denisenko E, Guo BB, Jones M, Hou R, De Kock L, Lassmann T, et al. Systematic assessment of tissue dissociation and storage biases in single-cell and single-nucleus RNA-seq workflows. Genome Biol. 2020;21:1\u201325.","journal-title":"Genome Biol"},{"issue":"2","key":"1085_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1182\/blood.2019001239","volume":"135","author":"CD DiNardo","year":"2020","unstructured":"DiNardo CD, Wei AH. How I treat acute myeloid leukemia in the era of new drugs. Blood. 2020;135(2):85\u201396.","journal-title":"Blood"},{"issue":"7","key":"1085_CR36","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2012971","volume":"383","author":"CD DiNardo","year":"2020","unstructured":"DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, et al. Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N Engl J Med. 2020a;383(7):617\u201329.","journal-title":"N Engl J Med"},{"issue":"13","key":"1085_CR37","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1093\/bioinformatics\/btv122","volume":"31","author":"B Ding","year":"2015","unstructured":"Ding B, Zheng L, Zhu Y, Li N, Jia H, Ai R, et al. Normalization and noise reduction for single cell RNA-seq experiments. Bioinformatics. 2015;31(13):2225\u20137.","journal-title":"Bioinformatics"},{"issue":"12","key":"1085_CR38","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H Dohner","year":"2022","unstructured":"Dohner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377.","journal-title":"Blood"},{"issue":"6","key":"1085_CR39","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1158\/2159-8290.CD-20-1375","volume":"11","author":"C Duy","year":"2021","unstructured":"Duy C, Li M, Teater M, Meydan C, Garrett-Bakelman FE, Lee TC, et al. Chemotherapy induces senescence-like resilient cells capable of initiating AML recurrence. Cancer Discov. 2021;11(6):1542\u201361.","journal-title":"Cancer Discov"},{"issue":"23","key":"1085_CR40","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1182\/bloodadvances.2020002997","volume":"4","author":"J-N Eckardt","year":"2020","unstructured":"Eckardt J-N, Bornh\u00e4user M, Wendt K, Middeke JM. Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects. Blood Adv. 2020;4(23):6077\u201385.","journal-title":"Blood Adv"},{"issue":"4","key":"1085_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1182\/blood.2021014670","volume":"141","author":"A Ediriwickrema","year":"2023","unstructured":"Ediriwickrema A, Gentles AJ, Majeti R. Single-cell genomics in AML: extending the frontiers of AML research. Blood. 2023;141(4):345\u201355.","journal-title":"Blood"},{"key":"1085_CR42","first-page":"705","volume":"26","author":"BR Fadl","year":"2020","unstructured":"Fadl BR, Brodie SA, Malasky M, Boland JF, Kelly MC, Kelley MW, et al. An optimized protocol for retina single-cell RNA sequencing. Mol vis. 2020;26:705.","journal-title":"Mol vis"},{"issue":"7","key":"1085_CR43","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","volume":"7","author":"T Farge","year":"2017","unstructured":"Farge T, Saland E, De Toni F, Aroua N, Hosseini M, Perry R, et al. Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism. Cancer Discov. 2017;7(7):716\u201335.","journal-title":"Cancer Discov"},{"issue":"3","key":"1085_CR44","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/bjc.2012.581","volume":"108","author":"R Fisher","year":"2013","unstructured":"Fisher R, Pusztai L, Swanton C. Cancer heterogeneity: implications for targeted therapeutics. Br J Cancer. 2013;108(3):479\u201385.","journal-title":"Br J Cancer"},{"issue":"15","key":"1085_CR45","first-page":"261","volume":"120","author":"K Fleischhauer","year":"2023","unstructured":"Fleischhauer K, Tran TH, Meisel R, Mytilineos J, Dreger P, Kroger N. Donor selection for allogeneic hematopoietic cell transplantation. Dtsch Arztebl Int. 2023;120(15):261\u20138.","journal-title":"Dtsch Arztebl Int"},{"issue":"12","key":"1085_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2020.108530","volume":"33","author":"MA Florez","year":"2020","unstructured":"Florez MA, Matatall KA, Jeong Y, Ortinau L, Shafer PW, Lynch AM, et al. Interferon gamma mediates hematopoietic stem cell activation and niche relocalization through BST2. Cell Rep. 2020;33(12):1.","journal-title":"Cell Rep"},{"key":"1085_CR47","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.omto.2022.09.001","volume":"27","author":"S-I Fujii","year":"2022","unstructured":"Fujii S-I, Kawamata T, Shimizu K, Nakabayashi J, Yamasaki S, Iyoda T, et al. Reinvigoration of innate and adaptive immunity via therapeutic cellular vaccine for patients with AML. Mol Therapy Oncolyt. 2022;27:315\u201332.","journal-title":"Mol Therapy Oncolyt."},{"key":"1085_CR48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3389\/fcell.2019.00207","volume":"7","author":"V Gambacorta","year":"2019","unstructured":"Gambacorta V, Gnani D, Vago L, Di Micco R. Epigenetic therapies for acute myeloid leukemia and their immune-related effects. Front Cell Dev Biol. 2019;7:207.","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"1085_CR49","doi-asserted-by":"publisher","first-page":"602","DOI":"10.2174\/1389202921999200625220812","volume":"21","author":"C Gao","year":"2020","unstructured":"Gao C, Zhang M, Chen L. The comparison of two single-cell sequencing platforms: BD rhapsody and 10x genomics chromium. Curr Genomics. 2020;21(8):602\u20139.","journal-title":"Curr Genomics"},{"issue":"13","key":"1085_CR50","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3390\/cells12131755","volume":"12","author":"L Gedefaw","year":"2023","unstructured":"Gedefaw L, Liu CF, Ip RKL, Tse HF, Yeung MHY, Yip SP, et al. Artificial intelligence-assisted diagnostic cytology and genomic testing for hematologic disorders. Cells. 2023;12(13):1755.","journal-title":"Cells"},{"key":"1085_CR51","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/1873-3468.13623","volume":"594","author":"S Geng","year":"2019","unstructured":"Geng S, Wang J, Zhang X, Zhang JJ, Wu F, Pang Y, Zhong Y, Wang J, Wang W, Lyu X, Huang Y. Single-cell RNA sequencing reveals chemokine self-feeding of myeloma cells promotes extramedullary metastasis. FEBS Lett. 2019;594:452\u201365.","journal-title":"FEBS Lett"},{"key":"1085_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.977358","volume":"13","author":"M Gimeno","year":"2022","unstructured":"Gimeno M, San Jose-Eneriz E, Villar S, Agirre X, Prosper F, Rubio A, et al. Explainable artificial intelligence for precision medicine in acute myeloid leukemia. Front Immunol. 2022;13: 977358.","journal-title":"Front Immunol"},{"issue":"2","key":"1085_CR53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41577-022-00675-7","volume":"22","author":"F Ginhoux","year":"2022","unstructured":"Ginhoux F, Guilliams M, Merad M. Expanding dendritic cell nomenclature in the single-cell era. Nat Rev Immunol. 2022;22(2):67\u20138.","journal-title":"Nat Rev Immunol"},{"key":"1085_CR54","doi-asserted-by":"publisher","first-page":"608916","DOI":"10.3389\/fonc.2020.608916","volume":"10","author":"SR Goldsmith","year":"2020","unstructured":"Goldsmith SR, Ghobadi A, DiPersio JF. Hematopoeitic Cell Transplantation and CAR T-Cell Therapy: Complements or competitors? Front Oncol. 2020;10:608916.","journal-title":"Front Oncol"},{"issue":"11","key":"1085_CR55","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jtct.2022.07.015","volume":"28","author":"SR Goldsmith","year":"2022","unstructured":"Goldsmith SR, Ghobadi A, Dipersio JF, Hill B, Shadman M, Jain T. Chimeric antigen receptor T Cell therapy versus hematopoietic stem cell transplantation: an evolving perspective. Transplant Cell Ther. 2022;28(11):727\u201336.","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"1085_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jitc-2021-003392","volume":"10","author":"M Goswami","year":"2022","unstructured":"Goswami M, Gui G, Dillon LW, Lindblad KE, Thompson J, Valdez J, et al. Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia. J Immunotherapy Cancer. 2022;10(1):1.","journal-title":"J Immunotherapy Cancer."},{"issue":"11","key":"1085_CR57","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/s41587-023-01684-0","volume":"41","author":"A Gottschlich","year":"2023","unstructured":"Gottschlich A, Thomas M, Grunmeier R, Lesch S, Rohrbacher L, Igl V, et al. Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia. Nat Biotechnol. 2023;41(11):1618\u201332.","journal-title":"Nat Biotechnol"},{"issue":"7381","key":"1085_CR58","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature10762","volume":"481","author":"M Greaves","year":"2012","unstructured":"Greaves M, Maley CC. Clonal evolution in cancer. Nature. 2012;481(7381):306\u201313.","journal-title":"Nature"},{"issue":"49","key":"1085_CR59","doi-asserted-by":"publisher","first-page":"19802","DOI":"10.1073\/pnas.1319700110","volume":"110","author":"RV Grindberg","year":"2013","unstructured":"Grindberg RV, Yee-Greenbaum JL, McConnell MJ, Novotny M, O\u2019Shaughnessy AL, Lambert GM, et al. RNA-sequencing from single nuclei. Proc Natl Acad Sci. 2013;110(49):19802\u20137.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"1085_CR60","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/jcm12041279","volume":"12","author":"Y Gui","year":"2023","unstructured":"Gui Y, He X, Yu J, Jing J. Artificial intelligence-assisted transcriptomic analysis to advance cancer immunotherapy. J Clin Med. 2023;12(4):1279.","journal-title":"J Clin Med"},{"issue":"2","key":"1085_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jitc-2023-008318","volume":"12","author":"S Guo","year":"2024","unstructured":"Guo S, Mohan GS, Wang B, Li T, Daver N, Zhao Y, et al. Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia. J Immunother Cancer. 2024;12(2):1.","journal-title":"J Immunother Cancer"},{"key":"1085_CR62","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.trsl.2017.07.007","volume":"189","author":"SD Gupta","year":"2017","unstructured":"Gupta SD, Sachs Z. Novel single-cell technologies in acute myeloid leukemia research. Transl Res. 2017;189:123\u201335.","journal-title":"Transl Res"},{"issue":"1","key":"1085_CR63","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister C, Satija R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 2019;20(1):296.","journal-title":"Genome Biol"},{"issue":"10","key":"1085_CR64","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.molonc.2015.10.016","volume":"9","author":"L Hammerich","year":"2015","unstructured":"Hammerich L, Binder A, Brody JD. In situ vaccination: cancer immunotherapy both personalized and off-the-shelf. Mol Oncol. 2015;9(10):1966\u201381.","journal-title":"Mol Oncol"},{"key":"1085_CR65","first-page":"105","volume":"3","author":"E Hatzimichael","year":"2010","unstructured":"Hatzimichael E, Tuthill M. Hematopoietic stem cell transplantation. Stem Cells Cloning. 2010;3:105\u201317.","journal-title":"Stem Cells Cloning"},{"issue":"1","key":"1085_CR66","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41375-018-0180-3","volume":"33","author":"S Haubner","year":"2019","unstructured":"Haubner S, Perna F, Kohnke T, Schmidt C, Berman S, Augsberger C, et al. Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML. Leukemia. 2019;33(1):64\u201374.","journal-title":"Leukemia"},{"key":"1085_CR67","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1200\/JCO.2013.51.4307","volume":"31","author":"T-C Ho","year":"2013","unstructured":"Ho T-C, Becker MW. Defining patient-specific risk in acute myeloid leukemia. Am Soc Clin Oncol. 2013;31:3857\u20139.","journal-title":"Am Soc Clin Oncol"},{"issue":"3","key":"1085_CR68","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nri.2017.131","volume":"18","author":"Z Hu","year":"2018","unstructured":"Hu Z, Ott PA, Wu CJ. Towards personalized, tumour-specific, therapeutic vaccines for cancer. Nat Rev Immunol. 2018;18(3):168\u201382.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1085_CR69","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13045-023-01494-6","volume":"16","author":"D Huang","year":"2023","unstructured":"Huang D, Ma N, Li X, Gou Y, Duan Y, Liu B, et al. Advances in single-cell RNA sequencing and its applications in cancer research. J Hematol Oncol. 2023;16(1):98.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"1085_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0071-8","volume":"50","author":"B Hwang","year":"2018","unstructured":"Hwang B, Lee JH, Bang D. Single-cell RNA sequencing technologies and bioinformatics pipelines. Exp Mol Med. 2018;50(8):1\u201314.","journal-title":"Exp Mol Med"},{"issue":"1","key":"1085_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-016-0888-1","volume":"17","author":"T Ilicic","year":"2016","unstructured":"Ilicic T, Kim JK, Kolodziejczyk AA, Bagger FO, McCarthy DJ, Marioni JC, et al. Classification of low quality cells from single-cell RNA-seq data. Genome Biol. 2016;17(1):1\u201315.","journal-title":"Genome Biol"},{"issue":"2","key":"1085_CR72","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nmeth.2772","volume":"11","author":"S Islam","year":"2014","unstructured":"Islam S, Zeisel A, Joost S, La Manno G, Zajac P, Kasper M, et al. Quantitative single-cell RNA-seq with unique molecular identifiers. Nat Methods. 2014;11(2):163\u20136.","journal-title":"Nat Methods"},{"issue":"3","key":"1085_CR73","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrd2804","volume":"8","author":"R Jefferis","year":"2009","unstructured":"Jefferis R. Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov. 2009;8(3):226\u201334.","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"1085_CR74","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/stem.2870","volume":"36","author":"S-Y Jeong","year":"2018","unstructured":"Jeong S-Y, Kim J-A, Oh I-H. The adaptive remodeling of stem cell niche in stimulated bone marrow counteracts the leukemic niche. Stem Cells. 2018;36(10):1617\u201329.","journal-title":"Stem Cells"},{"key":"1085_CR75","doi-asserted-by":"publisher","first-page":"1179859","DOI":"10.3389\/fgene.2023.1179859","volume":"14","author":"L Jiao","year":"2023","unstructured":"Jiao L, Ren Y, Wang L, Gao C, Wang S, Song T. MulCNN: An efficient and accurate deep learning method based on gene embedding for cell type identification in single-cell RNA-seq data. Front Genet. 2023;14:1179859.","journal-title":"Front Genet"},{"issue":"4","key":"1085_CR76","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41375-021-01432-w","volume":"36","author":"DT Johnson","year":"2022","unstructured":"Johnson DT, Zhou J, Kroll AV, Fang RH, Yan M, Xiao C, et al. Acute myeloid leukemia cell membrane-coated nanoparticles for cancer vaccination immunotherapy. Leukemia. 2022;36(4):994\u20131005.","journal-title":"Leukemia"},{"issue":"3","key":"1085_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.694","volume":"12","author":"D Jovic","year":"2022","unstructured":"Jovic D, Liang X, Zeng H, Lin L, Xu F, Luo Y. Single-cell RNA sequencing technologies and applications: a brief overview. Clin Transl Med. 2022;12(3): e694.","journal-title":"Clin Transl Med"},{"issue":"17","key":"1085_CR78","first-page":"3890","volume":"119","author":"G Juliusson","year":"2012","unstructured":"Juliusson G, Lazarevic V, H\u00f6rstedt A-S, Hagberg O, H\u00f6glund M. Acute myeloid leukemia in the real world: why population-based registries are needed. Blood J Am Soc Hematol. 2012;119(17):3890\u20139.","journal-title":"Blood J Am Soc Hematol"},{"issue":"17","key":"1085_CR79","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.3390\/cells12172159","volume":"12","author":"M Kaczmarek","year":"2023","unstructured":"Kaczmarek M, Pozna\u0144ska J, Fechner F, Michalska N, Paszkowska S, Napiera\u0142a A, et al. Cancer vaccine therapeutics: limitations and effectiveness\u2014a literature review. Cells. 2023a;12(17):2159.","journal-title":"Cells"},{"issue":"17","key":"1085_CR80","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.3390\/cells12172159","volume":"12","author":"M Kaczmarek","year":"2023","unstructured":"Kaczmarek M, Pozna\u0144ska J, Fechner F, Michalska N, Paszkowska S, Napiera\u0142a A, Mackiewicz A. Cancer vaccine therapeutics: limitations and effectiveness\u2014a literature review. Cells. 2023b;12(17):2159.","journal-title":"Cells"},{"issue":"11","key":"1085_CR81","doi-asserted-by":"publisher","first-page":"2200084","DOI":"10.1002\/bies.202200084","volume":"44","author":"M Ke","year":"2022","unstructured":"Ke M, Elshenawy B, Sheldon H, Arora A, Buffa FM. Single cell RNA-sequencing: a powerful yet still challenging technology to study cellular heterogeneity. BioEssays. 2022;44(11):2200084.","journal-title":"BioEssays"},{"issue":"11","key":"1085_CR82","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1158\/0008-5472.CAN-14-3379","volume":"75","author":"J-A Kim","year":"2015","unstructured":"Kim J-A, Shim J-S, Lee G-Y, Yim HW, Kim T-M, Kim M, et al. Microenvironmental remodeling as a parameter and prognostic factor of heterogeneous leukemogenesis in acute myelogenous leukemia. Can Res. 2015;75(11):2222\u201331.","journal-title":"Can Res"},{"issue":"6","key":"1085_CR83","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1093\/bib\/bby076","volume":"20","author":"T Kim","year":"2019","unstructured":"Kim T, Chen IR, Lin Y, Wang AY-Y, Yang JYH, Yang P. Impact of similarity metrics on single-cell RNA-seq data clustering. Brief Bioinfor. 2019;20(6):2316\u201326.","journal-title":"Brief Bioinfor"},{"issue":"5","key":"1085_CR84","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nmeth.4236","volume":"14","author":"VY Kiselev","year":"2017","unstructured":"Kiselev VY, Kirschner K, Schaub MT, Andrews T, Yiu A, Chandra T, et al. SC3: consensus clustering of single-cell RNA-seq data. Nat Methods. 2017;14(5):483\u20136.","journal-title":"Nat Methods"},{"issue":"4","key":"1085_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2023.112304","volume":"42","author":"A Konturek-Ciesla","year":"2023","unstructured":"Konturek-Ciesla A, Dhapola P, Zhang Q, S\u00e4w\u00e9n P, Wan H, Karlsson G, et al. Temporal multimodal single-cell profiling of native hematopoiesis illuminates altered differentiation trajectories with age. Cell Rep. 2023;42(4):1.","journal-title":"Cell Rep"},{"issue":"7","key":"1085_CR86","first-page":"811","volume":"129","author":"C Korn","year":"2017","unstructured":"Korn C, M\u00e9ndez-Ferrer S. Myeloid malignancies and the microenvironment. Blood J Am Soc Hematol. 2017;129(7):811\u201322.","journal-title":"Blood J Am Soc Hematol"},{"issue":"12","key":"1085_CR87","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1007\/s00262-022-03202-8","volume":"71","author":"S Kreutmair","year":"2022","unstructured":"Kreutmair S, Pfeifer D, Waterhouse M, Tak\u00e1cs F, Graessel L, D\u00f6hner K, et al. First-in-human study of WT1 recombinant protein vaccination in elderly patients with AML in remission: a single-center experience. Cancer Immunol Immunother. 2022;71(12):2913\u201328.","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"1085_CR88","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nprot.2016.015","volume":"11","author":"SR Krishnaswami","year":"2016","unstructured":"Krishnaswami SR, Grindberg RV, Novotny M, Venepally P, Lacar B, Bhutani K, et al. Using single nuclei for RNA-seq to capture the transcriptome of postmortem neurons. Nat Protoc. 2016;11(3):499\u2013524.","journal-title":"Nat Protoc"},{"issue":"4","key":"1085_CR89","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/bmt.2012.172","volume":"48","author":"S Kurosawa","year":"2013","unstructured":"Kurosawa S, Yakushijin K, Yamaguchi T, Atsuta Y, Nagamura-Inoue T, Akiyama H, et al. Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia\/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry. Bone Marrow Transplant. 2013;48(4):529\u201336.","journal-title":"Bone Marrow Transplant"},{"key":"1085_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-020-1926-6","volume":"21","author":"D L\u00e4hnemann","year":"2020","unstructured":"L\u00e4hnemann D, K\u00f6ster J, Szczurek E, McCarthy DJ, Hicks SC, Robinson MD, et al. Eleven grand challenges in single-cell data science. Genome Biol. 2020;21:1\u201335.","journal-title":"Genome Biol"},{"issue":"2","key":"1085_CR91","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/gtmb.2018.0211","volume":"24","author":"EM Lancaster","year":"2020","unstructured":"Lancaster EM, Jablons D, Kratz JR. Applications of next-generation sequencing in neoantigen prediction and cancer vaccine development. Genet Test Mol Biomarkers. 2020;24(2):59\u201366.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"1","key":"1085_CR92","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13045-021-01105-2","volume":"14","author":"Y Lei","year":"2021","unstructured":"Lei Y, Tang R, Xu J, Wang W, Zhang B, Liu J, et al. Applications of single-cell sequencing in cancer research: progress and perspectives. J Hematol Oncol. 2021;14(1):91.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1085_CR93","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1038\/s41467-020-15851-3","volume":"11","author":"X Li","year":"2020","unstructured":"Li X, Wang K, Lyu Y, Pan H, Zhang J, Stambolian D, et al. Deep learning enables accurate clustering with batch effect removal in single-cell RNA-seq analysis. Nat Commun. 2020;11(1):2338.","journal-title":"Nat Commun"},{"issue":"2","key":"1085_CR94","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41375-022-01789-6","volume":"37","author":"K Li","year":"2023","unstructured":"Li K, Du Y, Cai Y, Liu W, Lv Y, Huang B, et al. Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed\/refractory acute myeloid leukemia. Leukemia. 2023;37(2):308\u201325.","journal-title":"Leukemia"},{"issue":"4","key":"1085_CR95","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.3390\/ijms25042416","volume":"25","author":"YM Liao","year":"2024","unstructured":"Liao YM, Hsu SH, Chiou SS. Harnessing the Transcriptional Signatures of CAR-T-Cells and Leukemia\/Lymphoma Using Single-Cell Sequencing Technologies. Int J Mol Sci. 2024;25(4):2416.","journal-title":"Int J Mol Sci"},{"issue":"Supplement_1","key":"1085_CR96","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1182\/blood-2019-129451","volume":"134","author":"J Liegel","year":"2019","unstructured":"Liegel J, Bhasin M, Pihan GA, Stroopinsky D, Thomas B, Sindhu S, et al. Transcriptome sequencing demonstrates unique signature associated with durable clinical response to DC\/AML Fusion Vaccine. Blood. 2019;134(Supplement_1):3832.","journal-title":"Blood"},{"issue":"Supplement 1","key":"1085_CR97","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1182\/blood-2023-190832","volume":"142","author":"J Liegel","year":"2023","unstructured":"Liegel J, Cheloni G, Chedid G, Gerhard G, Karagkouni D, Stone R, et al. Phase 1 Trial of Dendritic Cell\/AML fusion cell vaccine after allogeneic stem cell transplant in acute myeloid leukemia. Blood. 2023;142(Supplement 1):772.","journal-title":"Blood"},{"key":"1085_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/f1000research.7223.1","volume":"5","author":"S Liu","year":"2016","unstructured":"Liu S, Trapnell C. Single-cell transcriptome sequencing: recent advances and remaining challenges. F1000Research. 2016;5:1.","journal-title":"F1000Research."},{"key":"1085_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.655536","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Fan Z, Zhao W, Zhou X. Machine intelligence in single-cell data analysis: advances and new challenges. Front Genet. 2021;12: 655536.","journal-title":"Front Genet"},{"issue":"1","key":"1085_CR100","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40164-024-00479-6","volume":"13","author":"J Liu","year":"2024","unstructured":"Liu J, Jiang P, Lu Z, Yu Z, Qian P. Decoding leukemia at the single-cell level: clonal architecture, classification, microenvironment, and drug resistance. Exp Hematol Oncol. 2024;13(1):12.","journal-title":"Exp Hematol Oncol"},{"issue":"12","key":"1085_CR101","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41592-018-0229-2","volume":"15","author":"R Lopez","year":"2018","unstructured":"Lopez R, Regier J, Cole MB, Jordan MI, Yosef N. Deep generative modeling for single-cell transcriptomics. Nat Methods. 2018;15(12):1053\u20138.","journal-title":"Nat Methods"},{"issue":"2","key":"1085_CR102","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nmeth.2804","volume":"11","author":"D Lovatt","year":"2014","unstructured":"Lovatt D, Ruble BK, Lee J, Dueck H, Kim TK, Fisher S, et al. Transcriptome in vivo analysis (TIVA) of spatially defined single cells in live tissue. Nat Methods. 2014;11(2):190\u20136.","journal-title":"Nat Methods"},{"key":"1085_CR103","doi-asserted-by":"publisher","first-page":"990034","DOI":"10.3389\/fcell.2022.990034","volume":"10","author":"J Lu","year":"2022","unstructured":"Lu J, Zheng G, Dong A, Chang X, Cao X, Liu M, Shi X, Wang C, Yang Y, Jia X. Prognostic characteristics of immune subtypes associated with acute myeloid leukemia and their identification in cell subsets based on single-cell sequencing analysis. Front Cell Dev Biol. 2022;10:990034.","journal-title":"Front Cell Dev Biol."},{"issue":"5","key":"1085_CR104","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cell.2015.05.002","volume":"161","author":"EZ Macosko","year":"2015","unstructured":"Macosko EZ, Basu A, Satija R, Nemesh J, Shekhar K, Goldman M, et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell. 2015;161(5):1202\u201314.","journal-title":"Cell"},{"issue":"1","key":"1085_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/diseases12010001","volume":"12","author":"L Madaci","year":"2023","unstructured":"Madaci L, Gard C, Nin S, Sarrabay A, Baier C, Venton G, et al. Single-Cell transcriptome analysis of acute myeloid leukemia cells using methanol fixation and cryopreservation. Diseases. 2023;12(1):1.","journal-title":"Diseases"},{"issue":"1","key":"1085_CR106","first-page":"26","volume":"106","author":"V Madan","year":"2021","unstructured":"Madan V, Koeffler HP. Differentiation therapy of myeloid leukemia: four decades of development. Haematologica. 2021;106(1):26.","journal-title":"Haematologica"},{"key":"1085_CR107","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1158\/2159-8290.CD-21-0410","volume":"12","author":"D Malani","year":"2022","unstructured":"Malani D, Kumar A, Br\u00fcck O, Kontro M, Yadav B, Helles\u00f8y M, Kuusanm\u00e4ki H, Dufva O, Kankainen M, Eldfors S, Potdar S. Implementing a functional precision medicine tumor board for acute myeloid leukemia. Cancer Discov. 2022;12:388\u2013401.","journal-title":"Cancer Discov"},{"issue":"1","key":"1085_CR108","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","volume":"9","author":"F Malard","year":"2023","unstructured":"Malard F, Holler E, Sandmaier BM, Huang H, Mohty M. Acute graft-versus-host disease. Nat Rev Dis Primers. 2023;9(1):27.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1085_CR109","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41467-019-14018-z","volume":"11","author":"M Marouf","year":"2020","unstructured":"Marouf M, Machart P, Bansal V, Kilian C, Magruder DS, Krebs CF, et al. Realistic in silico generation and augmentation of single-cell RNA-seq data using generative adversarial networks. Nature Commun. 2020;11(1):166.","journal-title":"Nature Commun"},{"issue":"5","key":"1085_CR110","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41556-020-0497-9","volume":"22","author":"S Martinez-H\u00f8yer","year":"2020","unstructured":"Martinez-H\u00f8yer S, Deng Y, Parker J, Jiang J, Mo A, Docking TR, et al. Loss of lenalidomide-induced megakaryocytic differentiation leads to therapy resistance in del (5q) myelodysplastic syndrome. Nat Cell Biol. 2020;22(5):526\u201333.","journal-title":"Nat Cell Biol"},{"issue":"13","key":"1085_CR111","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1182\/blood.2023021815","volume":"143","author":"A Mathioudaki","year":"2024","unstructured":"Mathioudaki A, Wang X, Sedloev D, Huth R, Kamal A, Hundemer M, et al. The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature. Blood. 2024;143(13):1269\u201381.","journal-title":"Blood"},{"key":"1085_CR112","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00277-018-3304-y","volume":"97","author":"JE Meg\u00edas-Vericat","year":"2018","unstructured":"Meg\u00edas-Vericat JE, Mart\u00ednez-Cuadr\u00f3n D, Sanz M\u00c1, Montesinos P. Salvage regimens using conventional chemotherapy agents for relapsed\/refractory adult AML patients: a systematic literature review. Ann Hematol. 2018;97:1115\u201353.","journal-title":"Ann Hematol"},{"issue":"3","key":"1085_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jitc-2021-003882","volume":"10","author":"NK Mehta","year":"2022","unstructured":"Mehta NK, Pfluegler M, Meetze K, Li B, Sindel I, Vogt F, et al. A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL. J Immunother Cancer. 2022;10(3):1.","journal-title":"J Immunother Cancer"},{"key":"1085_CR114","doi-asserted-by":"crossref","unstructured":"Mohammad Lotfollahi FAWaFJT. scGen predicts single-cell perturbation responses. Nature methods. 2019.","DOI":"10.1038\/s41592-019-0494-8"},{"issue":"6","key":"1085_CR115","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3390\/biom11060793","volume":"11","author":"J Moran-Sanchez","year":"2021","unstructured":"Moran-Sanchez J, Santisteban-Espejo A, Martin-Piedra MA, Perez-Requena J, Garcia-Rojo M. Translational applications of artificial intelligence and machine learning for diagnostic pathology in lymphoid neoplasms: a comprehensive and evolutive analysis. Biomolecules. 2021;11(6):793.","journal-title":"Biomolecules"},{"issue":"1","key":"1085_CR116","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/s41467-023-36969-0","volume":"14","author":"MM Naldini","year":"2023","unstructured":"Naldini MM, Casirati G, Barcella M, Rancoita PMV, Cosentino A, Caserta C, et al. Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia. Nat Commun. 2023;14(1):1285.","journal-title":"Nat Commun"},{"issue":"7633","key":"1085_CR117","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature20598","volume":"540","author":"SW Ng","year":"2016","unstructured":"Ng SW, Mitchell A, Kennedy JA, Chen WC, McLeod J, Ibrahimova N, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540(7633):433\u20137.","journal-title":"Nature"},{"key":"1085_CR118","first-page":"925","volume":"2020","author":"G Nicora","year":"2020","unstructured":"Nicora G, Bellazzi R. A reliable machine learning approach applied to single-cell classification in acute myeloid leukemia. AMIA Ann Symp Proc AMIA Symp. 2020;2020:925\u201332.","journal-title":"AMIA Ann Symp Proc AMIA Symp"},{"issue":"9","key":"1085_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101159","volume":"14","author":"L-T Niu","year":"2021","unstructured":"Niu L-T, Wang Y-Q, Wong CC, Gao S-X, Mo X-D, Huang X-J. Targeting IFN-\u03b3-inducible lysosomal thiol reductase overcomes chemoresistance in AML through regulating the ROS-mediated mitochondrial damage. Translational Oncology. 2021;14(9): 101159.","journal-title":"Translational Oncology"},{"key":"1085_CR120","doi-asserted-by":"publisher","first-page":"8624963","DOI":"10.1155\/2020\/8624963","volume":"2020","author":"A Noe","year":"2020","unstructured":"Noe A, Cargill TN, Nielsen CM, Russell AJC, Barnes E. The application of single-Cell RNA sequencing in vaccinology. J Immunol Res. 2020;2020:8624963.","journal-title":"J Immunol Res"},{"key":"1085_CR121","doi-asserted-by":"publisher","first-page":"1114368","DOI":"10.3389\/fimmu.2023.1114368","volume":"14","author":"B Obermayer","year":"2023","unstructured":"Obermayer B, Keilholz L, Conrad T, Frentsch M, Blau IW, Vuong L, et al. Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation. Front Immunol. 2023;14:1114368.","journal-title":"Front Immunol"},{"issue":"1","key":"1085_CR122","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/s41467-019-10291-0","volume":"10","author":"D Pellin","year":"2019","unstructured":"Pellin D, Loperfido M, Baricordi C, Wolock SL, Montepeloso A, Weinberg OK, et al. A comprehensive single cell transcriptional landscape of human hematopoietic progenitors. Nature Commun. 2019;10(1):2395.","journal-title":"Nature Commun"},{"issue":"1","key":"1085_CR123","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13046-023-02841-8","volume":"42","author":"E Peroni","year":"2023","unstructured":"Peroni E, Randi ML, Rosato A, Cagnin S. Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. Dissect cancer heterogeneity and tailor the treatment. J Exp Clin Cancer Res CR. 2023;42(1):259.","journal-title":"J Exp Clin Cancer Res CR."},{"issue":"1","key":"1085_CR124","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1038\/s41467-019-11591-1","volume":"10","author":"AA Petti","year":"2019","unstructured":"Petti AA, Williams SR, Miller CA, Fiddes IT, Srivatsan SN, Chen DY, et al. A general approach for detecting expressed mutations in AML cells using single cell RNA-sequencing. Nat Commun. 2019;10(1):3660.","journal-title":"Nat Commun"},{"issue":"9","key":"1085_CR125","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1007\/s00277-023-05353-9","volume":"102","author":"A Pohlmann","year":"2023","unstructured":"Pohlmann A, Bentgens E, Schulke C, Kuron D, Reicherts C, Marx J, et al. Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML). Ann Hematol. 2023;102(9):2543\u201353.","journal-title":"Ann Hematol"},{"key":"1085_CR126","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.canep.2015.12.005","volume":"40","author":"JN Poynter","year":"2016","unstructured":"Poynter JN, Richardson M, Blair CK, Roesler MA, Hirsch BA, Nguyen P, et al. Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes. Cancer Epidemiol. 2016;40:134\u201340.","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"1085_CR127","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.blre.2016.08.005","volume":"31","author":"J Prada-Arismendy","year":"2017","unstructured":"Prada-Arismendy J, Arroyave JC, Rothlisberger S. Molecular biomarkers in acute myeloid leukemia. Blood Rev. 2017;31(1):63\u201376.","journal-title":"Blood Rev"},{"issue":"11","key":"1085_CR128","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3324\/haematol.2018.191536","volume":"103","author":"VV Prassek","year":"2018","unstructured":"Prassek VV, Rothenberg-Thurley M, Sauerland MC, Herold T, Janke H, Ksienzyk B, et al. Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older. Haematologica. 2018;103(11):1853\u201361.","journal-title":"Haematologica"},{"key":"1085_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2019.104441","volume":"99","author":"Z Qi","year":"2019","unstructured":"Qi Z, Barrett T, Parikh AS, Tirosh I, Puram SV. Single-cell sequencing and its applications in head and neck cancer. Oral Oncol. 2019;99: 104441.","journal-title":"Oral Oncol"},{"issue":"4","key":"1085_CR130","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/bib\/bbz062","volume":"21","author":"R Qi","year":"2020","unstructured":"Qi R, Ma A, Ma Q, Zou Q. Clustering and classification methods for single-cell RNA-sequencing data. Brief Bioinform. 2020;21(4):1196\u2013208.","journal-title":"Brief Bioinform"},{"key":"1085_CR131","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.663406","volume":"11","author":"R Radpour","year":"2021","unstructured":"Radpour R, Stucki M, Riether C, Ochsenbein AF. Epigenetic silencing of immune-checkpoint receptors in bone marrow- infiltrating T Cells in acute myeloid leukemia. Front Oncol. 2021;11: 663406.","journal-title":"Front Oncol"},{"issue":"1","key":"1085_CR132","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41467-017-02618-6","volume":"9","author":"K Ramaswamy","year":"2018","unstructured":"Ramaswamy K, Forbes L, Minuesa G, Gindin T, Brown F, Kharas MG, et al. Peptidomimetic blockade of MYB in acute myeloid leukemia. Nat Commun. 2018;9(1):110.","journal-title":"Nat Commun"},{"issue":"8","key":"1085_CR133","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nbt.2282","volume":"30","author":"D Ramsk\u00f6ld","year":"2012","unstructured":"Ramsk\u00f6ld D, Luo S, Wang Y-C, Li R, Deng Q, Faridani OR, et al. Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat Biotechnol. 2012;30(8):777\u201382.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"1085_CR134","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.bbmt.2015.10.019","volume":"22","author":"A Rashidi","year":"2016","unstructured":"Rashidi A, Ebadi M, Colditz GA, DiPersio JF. Outcomes of allogeneic stem cell transplantation in elderly patients with acute myeloid leukemia: a systematic review and meta-analysis. Biol Blood Marrow Transplant. 2016;22(4):651\u20137.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"1085_CR135","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41375-023-01884-2","volume":"37","author":"C Rausch","year":"2023","unstructured":"Rausch C, Rothenberg-Thurley M, Dufour A, Schneider S, Gittinger H, Sauerland C, et al. Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia. Leukemia. 2023;37(6):1234\u201344.","journal-title":"Leukemia"},{"issue":"3","key":"1085_CR136","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/cancers13030428","volume":"13","author":"E Renard","year":"2021","unstructured":"Renard E, Collado Camps E, Canovas C, Kip A, Gotthardt M, Rijpkema M, et al. Site-Specific Dual-Labeling of a VHH with a Chelator and a Photosensitizer for Nuclear Imaging and Targeted Photodynamic Therapy of EGFR-Positive Tumors. Cancers. 2021;13(3):428.","journal-title":"Cancers"},{"issue":"7","key":"1085_CR137","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1182\/blood.2019004583","volume":"136","author":"C Rollig","year":"2020","unstructured":"Rollig C, Kramer M, Schliemann C, Mikesch JH, Steffen B, Kramer A, et al. Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia? Blood. 2020;136(7):823\u201330.","journal-title":"Blood"},{"issue":"3","key":"1085_CR138","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1158\/2767-9764.CRC-23-0402","volume":"4","author":"JL Root","year":"2024","unstructured":"Root JL, Desai PN, Ly C, Wang B, Jelloul FZ, Zhou J, et al. Single-Cell CD4 and CD8 T-Cell secretome profiling reveals temporal and niche differences in acute myeloid leukemia following immune checkpoint blockade therapy. Cancer Res Commun. 2024;4(3):671\u201381.","journal-title":"Cancer Res Commun"},{"issue":"7","key":"1085_CR139","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.leukres.2012.02.022","volume":"36","author":"DB Rosen","year":"2012","unstructured":"Rosen DB, Cordeiro JA, Cohen A, Lacayo N, Hogge D, Hawtin RE, et al. Assessing signaling pathways associated with in vitro resistance to cytotoxic agents in AML. Leuk Res. 2012;36(7):900\u20134.","journal-title":"Leuk Res"},{"issue":"1","key":"1085_CR140","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3324\/haematol.2021.280161","volume":"107","author":"JM Rowe","year":"2022","unstructured":"Rowe JM. The \u201c7+ 3\u201d regimen in acute myeloid leukemia. Haematologica. 2022;107(1):3.","journal-title":"Haematologica"},{"issue":"10","key":"1085_CR141","doi-asserted-by":"publisher","first-page":"118785","DOI":"10.1016\/j.bbamcr.2020.118785","volume":"1867","author":"PP Ruvolo","year":"2020","unstructured":"Ruvolo PP, Ma H, Ruvolo VR, Zhang X, Post SM, Andreeff M. LGALS1 acts as a pro-survival molecule in AML. Biochimica Et Biophys Acta (BBA) Molecul Cell Res. 2020;1867(10):118785.","journal-title":"Biochimica Et Biophys Acta (BBA) Molecul Cell Res."},{"issue":"3","key":"1085_CR142","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1158\/0008-5472.CAN-18-2932","volume":"80","author":"K Sachs","year":"2020","unstructured":"Sachs K, Sarver AL, Noble-Orcutt KE, LaRue RS, Antony ML, Chang D, et al. Single-cell gene expression analyses reveal distinct self-renewing and proliferating subsets in the leukemia stem cell compartment in acute myeloid leukemia. Can Res. 2020;80(3):458\u201370.","journal-title":"Can Res"},{"key":"1085_CR143","doi-asserted-by":"crossref","unstructured":"Sadafi A, Hehr M, Navab N, Marr C. A Study of Age and Sex Bias in Multiple Instance Learning based Classification of Acute Myeloid Leukemia Subtypes. 2023.","DOI":"10.1007\/978-3-031-45249-9_25"},{"issue":"14","key":"1085_CR144","doi-asserted-by":"publisher","first-page":"8845","DOI":"10.1093\/nar\/gku555","volume":"42","author":"A-E Saliba","year":"2014","unstructured":"Saliba A-E, Westermann AJ, Gorski SA, Vogel J. Single-cell RNA-seq: advances and future challenges. Nucleic Acids Res. 2014;42(14):8845\u201360.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"1085_CR145","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1158\/2159-8290.CD-20-1145","volume":"12","author":"JM Salmon","year":"2022","unstructured":"Salmon JM, Todorovski I, Stanley KL, Bruedigam C, Kearney CJ, Martelotto LG, et al. Epigenetic activation of plasmacytoid DCs drives IFNAR-dependent therapeutic differentiation of AML. Cancer Discov. 2022;12(6):1560\u201379.","journal-title":"Cancer Discov"},{"key":"1085_CR146","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1182\/blood-2019-125578","volume":"134","author":"E San Jose","year":"2019","unstructured":"San Jose E, Gimenez-Camino N, Rabal O, Miranda E, Garate L, Garcia F, et al. Differentiation therapy with novel epigenetic inhibitors in acute myeloid leukemia. Blood. 2019;134:3762.","journal-title":"Blood"},{"key":"1085_CR147","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00018-016-2306-y","volume":"74","author":"A S\u00e1nchez-Aguilera","year":"2017","unstructured":"S\u00e1nchez-Aguilera A, M\u00e9ndez-Ferrer S. The hematopoietic stem-cell niche in health and leukemia. Cell Mol Life Sci. 2017;74:579\u201390.","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"1085_CR148","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/cncr.33458","volume":"127","author":"K Sasaki","year":"2021","unstructured":"Sasaki K, Ravandi F, Kadia TM, DiNardo CD, Short NJ, Borthakur G, et al. De novo acute myeloid leukemia: a population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017. Cancer. 2021;127(12):2049\u201361.","journal-title":"Cancer"},{"issue":"5","key":"1085_CR149","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija R, Farrell JA, Gennert D, Schier AF, Regev A. Spatial reconstruction of single-cell gene expression data. Nat Biotechnol. 2015;33(5):495\u2013502.","journal-title":"Nat Biotechnol"},{"issue":"Pt 1","key":"1085_CR150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/mic.0.049601-0","volume":"159","author":"M Saxena","year":"2013","unstructured":"Saxena M, Van TTH, Baird FJ, Coloe PJ, Smooker PM. Pre-existing immunity against vaccine vectors\u2013friend or foe? Microbiology (Reading, England). 2013;159(Pt 1):1\u201311.","journal-title":"Microbiology (Reading, England)"},{"issue":"11","key":"1085_CR151","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021110409","volume":"41","author":"J Schneider","year":"2022","unstructured":"Schneider J, Weigel J, Wittmann MT, Svehla P, Ehrt S, Zheng F, et al. Astrogenesis in the murine dentate gyrus is a life-long and dynamic process. EMBO J. 2022;41(11): e110409.","journal-title":"EMBO J"},{"issue":"4","key":"1085_CR152","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.stem.2014.01.002","volume":"14","author":"CM Sch\u00fcrch","year":"2014","unstructured":"Sch\u00fcrch CM, Riether C, Ochsenbein AF. Cytotoxic CD8+ T cells stimulate hematopoietic progenitors by promoting cytokine release from bone marrow mesenchymal stromal cells. Cell Stem Cell. 2014;14(4):460\u201372.","journal-title":"Cell Stem Cell"},{"issue":"7488","key":"1085_CR153","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature13038","volume":"506","author":"LI Shlush","year":"2014","unstructured":"Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V, et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature. 2014;506(7488):328\u201333.","journal-title":"Nature"},{"issue":"2","key":"1085_CR154","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/bjh.16915","volume":"192","author":"R Shouval","year":"2021","unstructured":"Shouval R, Fein JA, Savani B, Mohty M, Nagler A. Machine learning and artificial intelligence in haematology. Br J Haematol. 2021;192(2):239\u201350.","journal-title":"Br J Haematol"},{"issue":"1","key":"1085_CR155","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3390\/ijms24010563","volume":"24","author":"KA Skelding","year":"2022","unstructured":"Skelding KA, Barry DL, Theron DZ, Lincz LF. Bone marrow microenvironment as a source of new drug targets for the treatment of acute myeloid leukaemia. Int J Mol Sci. 2022;24(1):563.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1085_CR156","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41591-020-0844-1","volume":"26","author":"M Slyper","year":"2020","unstructured":"Slyper M, Porter CB, Ashenberg O, Waldman J, Drokhlyansky E, Wakiro I, et al. A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nat Med. 2020;26(5):792\u2013802.","journal-title":"Nat Med"},{"issue":"9","key":"1085_CR157","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/cac2.12189","volume":"41","author":"J Song","year":"2021","unstructured":"Song J, Du L, Liu P, Wang F, Zhang B, Xie Y, et al. Intra-heterogeneity in transcription and chemoresistant property of leukemia-initiating cells in murine Setd2\u2212\/\u2212 acute myeloid leukemia. Cancer Commun. 2021;41(9):867\u201388.","journal-title":"Cancer Commun"},{"issue":"17","key":"1085_CR158","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1001\/jama.2011.1558","volume":"306","author":"ML Sorror","year":"2011","unstructured":"Sorror ML, Sandmaier BM, Storer BE, Franke GN, Laport GG, Chauncey TR, et al. Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies. JAMA. 2011;306(17):1874\u201383.","journal-title":"JAMA"},{"key":"1085_CR159","doi-asserted-by":"crossref","unstructured":"Soudris D, Xydis S, Baloukas C, Hadzidimitriou A, Chouvarda I, Stamatopoulos K, et al., editors. AEGLE: A big bio-data analytics framework for integrated health-care services. 2015 International Conference on Embedded Computer Systems: Architectures, Modeling, and Simulation (SAMOS); 2015: IEEE.","DOI":"10.1109\/SAMOS.2015.7363682"},{"key":"1085_CR160","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.696791","volume":"12","author":"AJ Stephens","year":"2021","unstructured":"Stephens AJ, Burgess-Brown NA, Jiang S. Beyond just peptide antigens: the complex world of peptide-based cancer vaccines. Front Immunol. 2021;12: 696791.","journal-title":"Front Immunol"},{"issue":"10","key":"1085_CR161","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1038\/s41375-021-01338-7","volume":"35","author":"L Stetson","year":"2021","unstructured":"Stetson L, Balasubramanian D, Ribeiro SP, Stefan T, Gupta K, Xu X, et al. Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression. Leukemia. 2021;35(10):2799\u2013812.","journal-title":"Leukemia"},{"issue":"5","key":"1085_CR162","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.3324\/haematol.2020.259457","volume":"106","author":"D Stroopinsky","year":"2021","unstructured":"Stroopinsky D, Liegel J, Bhasin M, Cheloni G, Thomas B, Bhasin S, et al. Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia model. Haematologica. 2021;106(5):1330\u201342.","journal-title":"Haematologica"},{"issue":"12","key":"1085_CR163","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41408-021-00584-3","volume":"11","author":"RJ Stubbins","year":"2021","unstructured":"Stubbins RJ, Karsan A. Differentiation therapy for myeloid malignancies: beyond cytotoxicity. Blood Cancer J. 2021;11(12):193.","journal-title":"Blood Cancer J"},{"issue":"1","key":"1085_CR164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-019-1898-6","volume":"20","author":"S Sun","year":"2019","unstructured":"Sun S, Zhu J, Ma Y, Zhou X. Accuracy, robustness and scalability of dimensionality reduction methods for single-cell RNA-seq analysis. Genome Biol. 2019;20(1):1\u201321.","journal-title":"Genome Biol"},{"issue":"4","key":"1085_CR165","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nmeth.4220","volume":"14","author":"V Svensson","year":"2017","unstructured":"Svensson V, Natarajan KN, Ly L-H, Miragaia RJ, Labalette C, Macaulay IC, et al. Power analysis of single-cell RNA-sequencing experiments. Nat Methods. 2017;14(4):381\u20137.","journal-title":"Nat Methods"},{"issue":"1","key":"1085_CR166","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.1038\/s41598-020-61247-0","volume":"10","author":"S Syed-Abdul","year":"2020","unstructured":"Syed-Abdul S, Firdani RP, Chung HJ, Uddin M, Hur M, Park JH, et al. Artificial intelligence based models for screening of hematologic malignancies using cell population data. Sci Rep. 2020;10(1):4583.","journal-title":"Sci Rep"},{"issue":"4","key":"1085_CR167","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1159\/000510980","volume":"144","author":"S Takahashi","year":"2021","unstructured":"Takahashi S. Current understandings of myeloid differentiation inducers in leukemia therapy. Acta Haematol. 2021;144(4):380\u20138.","journal-title":"Acta Haematol"},{"issue":"3","key":"1085_CR168","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1182\/blood-2007-10-118331","volume":"112","author":"DC Taussig","year":"2008","unstructured":"Taussig DC, Miraki-Moud F, Anjos-Afonso F, Pearce DJ, Allen K, Ridler C, et al. Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood. 2008;112(3):568\u201375.","journal-title":"Blood"},{"issue":"3","key":"1085_CR169","first-page":"319","volume":"126","author":"F Thol","year":"2015","unstructured":"Thol F, Schlenk RF, Heuser M, Ganser A. How I treat refractory and early relapsed acute myeloid leukemia. Blood J Am Soc Hematol. 2015;126(3):319\u201327.","journal-title":"Blood J Am Soc Hematol"},{"issue":"4","key":"1085_CR170","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1182\/blood.V49.4.511.511","volume":"49","author":"ED Thomas","year":"1977","unstructured":"Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A, Flournoy N, et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood. 1977;49(4):511\u201333.","journal-title":"Blood"},{"key":"1085_CR171","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1056\/NEJM195709122571102","volume":"257","author":"ED Thomas Hllj","year":"1957","unstructured":"Thomas Hllj ED, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med. 1957;257:491\u20136.","journal-title":"N Engl J Med"},{"issue":"5","key":"1085_CR172","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s11899-019-00542-8","volume":"14","author":"P Torka","year":"2019","unstructured":"Torka P, Barth M, Ferdman R, Hernandez-Ilizaliturri FJ. Mechanisms of resistance to monoclonal antibodies (mAbs) in lymphoid malignancies. Curr Hematol Malig Rep. 2019;14(5):426\u201338.","journal-title":"Curr Hematol Malig Rep"},{"key":"1085_CR173","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.exphem.2022.04.002","volume":"111","author":"P Upadhyay","year":"2022","unstructured":"Upadhyay P, Beales J, Shah NM, Gruszczynska A, Miller CA, Petti AA, et al. Recurrent transcriptional responses in AML and MDS patients treated with decitabine. Exp Hematol. 2022;111:50\u201365.","journal-title":"Exp Hematol"},{"issue":"10","key":"1085_CR174","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nmeth.4437","volume":"14","author":"SC van den Brink","year":"2017","unstructured":"van den Brink SC, Sage F, V\u00e9rtesy \u00c1, Spanjaard B, Peterson-Maduro J, Baron CS, et al. Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations. Nat Methods. 2017;14(10):935\u20136.","journal-title":"Nat Methods"},{"issue":"6","key":"1085_CR175","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen P, Hovestadt V, Wadsworth MH II, Hughes TK, Griffin GK, Battaglia S, et al. Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity. Cell. 2019;176(6):1265-81.e24.","journal-title":"Cell"},{"issue":"6","key":"1085_CR176","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen P, Hovestadt V, Wadsworth Ii MH, Hughes TK, Griffin GK, Battaglia S, et al. Single-Cell RNA-Seq Reveals AML hierarchies relevant to disease progression and immunity. Cell. 2019;176(6):1265-81.e24.","journal-title":"Cell"},{"issue":"3","key":"1085_CR177","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41568-019-0230-9","volume":"20","author":"D Vetrie","year":"2020","unstructured":"Vetrie D, Helgason GV, Copland M. The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML. Nat Rev Cancer. 2020;20(3):158\u201373.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"1085_CR178","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/leu.2017.317","volume":"32","author":"V Walf-Vorderw\u00fclbecke","year":"2018","unstructured":"Walf-Vorderw\u00fclbecke V, Pearce K, Brooks T, Hubank M, Van Den Heuvel-Eibrink M, Zwaan C, et al. Targeting acute myeloid leukemia by drug-induced c-MYB degradation. Leukemia. 2018;32(4):882\u20139.","journal-title":"Leukemia"},{"issue":"7","key":"1085_CR179","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1007\/s12094-023-03108-6","volume":"25","author":"F Wang","year":"2023","unstructured":"Wang F. Identification of tumor antigens and immune subtypes of acute myeloid leukemia for mRNA vaccine development. Clin Transl Oncol. 2023;25(7):2204\u201323.","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"1085_CR180","first-page":"43","volume":"8","author":"Q Wang","year":"2019","unstructured":"Wang Q, Chen Y, Park J, Liu X, Hu Y, Wang T, et al. Design and Production of Bispecific Antibodies. Antibodies (Basel, Switzerland). 2019;8(3):43.","journal-title":"Antibodies (Basel, Switzerland)."},{"issue":"9","key":"1085_CR181","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41592-019-0537-1","volume":"16","author":"J Wang","year":"2019","unstructured":"Wang J, Agarwal D, Huang M, Hu G, Zhou Z, Ye C, et al. Data denoising with transfer learning in single-cell transcriptomics. Nat Methods. 2019;16(9):875\u20138.","journal-title":"Nat Methods"},{"issue":"1","key":"1085_CR182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-019-1764-6","volume":"20","author":"T Wang","year":"2019","unstructured":"Wang T, Johnson TS, Shao W, Lu Z, Helm BR, Zhang J, et al. BERMUDA: a novel deep transfer learning method for single-cell RNA sequencing batch correction reveals hidden high-resolution cellular subtypes. Genome Biol. 2019;20(1):1\u201315.","journal-title":"Genome Biol"},{"key":"1085_CR183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-021-02280-8","volume":"22","author":"D Wang","year":"2021","unstructured":"Wang D, Hou S, Zhang L, Wang X, Liu B, Zhang Z. iMAP: integration of multiple single-cell datasets by adversarial paired transfer networks. Genome Biol. 2021;22:1\u201324.","journal-title":"Genome Biol"},{"issue":"2","key":"1085_CR184","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3324\/haematol.2013.092072","volume":"99","author":"M Wetzler","year":"2014","unstructured":"Wetzler M, Mrozek K, Kohlschmidt J, Dombret H, Dohner H, Pilorge S, et al. Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classification. Haematologica. 2014;99(2):308\u201313.","journal-title":"Haematologica"},{"issue":"8","key":"1085_CR185","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3390\/jcm8081261","volume":"8","author":"BA Williams","year":"2019","unstructured":"Williams BA, Law A, Hunyadkurti J, Desilets S, Leyton JV, Keating A. Antibody therapies for acute myeloid leukemia: unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats. J Clin Med. 2019;8(8):1261.","journal-title":"J Clin Med"},{"key":"1085_CR186","doi-asserted-by":"publisher","first-page":"204062071986064","DOI":"10.1177\/2040620719860645","volume":"10","author":"ES Winer","year":"2019","unstructured":"Winer ES, Stone RM. Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approaches. Therapeutic Adv Hematol. 2019;10:2040620719860645.","journal-title":"Therapeutic Adv Hematol."},{"issue":"15","key":"1085_CR187","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.3390\/cancers14153780","volume":"14","author":"ANN Wong","year":"2022","unstructured":"Wong ANN, He Z, Leung KL, To CCK, Wong CY, Wong SCC, et al. Current developments of artificial intelligence in digital pathology and its future clinical applications in gastrointestinal cancers. Cancers (Basel). 2022;14(15):3780.","journal-title":"Cancers (Basel)."},{"key":"1085_CR188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-00941-y","volume":"13","author":"J Wu","year":"2020","unstructured":"Wu J, Xiao Y, Sun J, Sun H, Chen H, Zhu Y, Fu H, Yu C, E W, Lai S, Ma L, et al. A single-cell survey of cellular hierarchy in acute myeloid leukemia. J Hematol Oncol. 2020;13:1\u20139.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1085_CR189","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","volume":"19","author":"H Ye","year":"2016","unstructured":"Ye H, Adane B, Khan N, Sullivan T, Minhajuddin M, Gasparetto M, et al. Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche. Cell Stem Cell. 2016;19(1):23\u201337.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"1085_CR190","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41590-022-01215-0","volume":"23","author":"AT Yeo","year":"2022","unstructured":"Yeo AT, Rawal S, Delcuze B, Christofides A, Atayde A, Strauss L, et al. Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression. Nat Immunol. 2022;23(6):971\u201384.","journal-title":"Nat Immunol"},{"issue":"3","key":"1085_CR191","first-page":"34","volume":"9","author":"D Zahavi","year":"2020","unstructured":"Zahavi D, Weiner L. Monoclonal Antibodies in Cancer Therapy. Antibodies (Basel, Switzerland). 2020;9(3):34.","journal-title":"Antibodies (Basel, Switzerland)"},{"issue":"5","key":"1085_CR192","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s41375-018-0326-3","volume":"33","author":"W Zeijlemaker","year":"2019","unstructured":"Zeijlemaker W, Grob T, Meijer R, Hanekamp D, Kelder A, Carbaat-Ham JC, et al. CD34(+)CD38(-) leukemic stem cell frequency to predict outcome in acute myeloid leukemia. Leukemia. 2019;33(5):1102\u201312.","journal-title":"Leukemia"},{"issue":"1","key":"1085_CR193","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.molcel.2018.10.020","volume":"73","author":"X Zhang","year":"2019","unstructured":"Zhang X, Li T, Liu F, Chen Y, Yao J, Li Z, et al. Comparative analysis of droplet-based ultra-high-throughput single-cell RNA-seq systems. Mol Cell. 2019;73(1):130-42.e5.","journal-title":"Mol Cell"},{"key":"1085_CR194","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-021-01874-1","volume":"40","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wang D, Peng M, Tang L, Ouyang J, Xiong F, et al. Single-cell RNA sequencing in cancer research. J Exp Clin Cancer Res. 2021;40:1\u201317.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1085_CR195","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13287-022-02718-1","volume":"13","author":"P Zhang","year":"2022","unstructured":"Zhang P, Li X, Pan C, Zheng X, Hu B, Xie R, Hu J, Shang X, Yang H. Single-cell RNA sequencing to track novel perspectives in HSC heterogeneity. Stem Cell Res Therapy. 2022;13(1):39.","journal-title":"Stem Cell Res Therapy."},{"issue":"4","key":"1085_CR196","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.molcel.2017.01.023","volume":"65","author":"C Ziegenhain","year":"2017","unstructured":"Ziegenhain C, Vieth B, Parekh S, Reinius B, Guillaumet-Adkins A, Smets M, et al. Comparative analysis of single-cell RNA sequencing methods. Mol Cell. 2017;65(4):631-43.e4.","journal-title":"Mol Cell"},{"issue":"5","key":"1085_CR197","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/10245330410001727055","volume":"10","author":"G Zini","year":"2005","unstructured":"Zini G. Artificial intelligence in hematology. Hematology. 2005;10(5):393\u2013400.","journal-title":"Hematology"},{"issue":"3","key":"1085_CR198","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1002\/mog2.47","volume":"2","author":"Y Zou","year":"2023","unstructured":"Zou Y, Zhang H, Hu H. Big data and single-cell sequencing in acute myeloid leukemia research. MedComm Oncol. 2023;2(3):e47.","journal-title":"MedComm Oncol."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01085-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01085-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01085-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T13:39:36Z","timestamp":1738244376000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-025-01085-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":198,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1085"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01085-w","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"3 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable to this summary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable to this summary.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}